• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

端粒酶:膀胱冲洗液中膀胱移行细胞癌的潜在标志物。

Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.

作者信息

Lee D H, Yang S C, Hong S J, Chung B H, Kim I Y

机构信息

Department of Urology, Yonsei University College of Medicine, Seoul, Korea.

出版信息

Clin Cancer Res. 1998 Mar;4(3):535-8.

PMID:9533519
Abstract

Telomerase is an enzyme that immortalizes cells by maintaining a constant telomere length. Here, telomerase activity in bladder washes was analyzed and compared with the final pathological diagnosis in 23 patients with bladder transitional cell carcinoma (TCC). Bladder washes and normal tissues were obtained from each patient prior to transurethral resection of bladder tumor. Telomerase activity was detected using telomeric repeat amplification protocol assay based on PCR. Cytological diagnosis of centrifuged cells from bladder washes was made using Papanicolau's stain. Results demonstrated that telomerase activity was detected in 95.7% of both cancer tissues and bladder washes. In normal tissues, telomerase activity was not detected in 22 of 23 samples. Regarding cytological diagnosis, only 69.6% of bladder wash samples had positive cytology. Moreover, in five cases of grade 1 TCC, only 20% of the cytological specimens were positive for malignancy, whereas 80% showed positive telomerase activity. These results demonstrate that telomerase activity is detectable in a majority of human bladder cancer tissues and bladder washes obtained from patients with TCC. In addition, results of this study suggest that the presence of telomerase in bladder washes may be a specific marker of bladder cancer, especially in low-grade tumors.

摘要

端粒酶是一种通过维持端粒长度恒定使细胞永生化的酶。在此,对23例膀胱移行细胞癌(TCC)患者膀胱冲洗液中的端粒酶活性进行了分析,并与最终病理诊断结果进行了比较。在经尿道膀胱肿瘤切除术之前,从每位患者获取膀胱冲洗液和正常组织。基于PCR的端粒重复序列扩增法检测端粒酶活性。采用巴氏染色法对膀胱冲洗液离心后的细胞进行细胞学诊断。结果显示,95.7%的癌组织和膀胱冲洗液中检测到端粒酶活性。在正常组织中,23个样本中有22个未检测到端粒酶活性。关于细胞学诊断,仅69.6%的膀胱冲洗液样本细胞学检查呈阳性。此外,在5例1级TCC患者中,仅20%的细胞学标本恶性检查呈阳性,而80%显示端粒酶活性阳性。这些结果表明,在大多数人类膀胱癌组织以及TCC患者的膀胱冲洗液中可检测到端粒酶活性。此外,本研究结果提示,膀胱冲洗液中端粒酶的存在可能是膀胱癌的一个特异性标志物,尤其是在低级别肿瘤中。

相似文献

1
Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.端粒酶:膀胱冲洗液中膀胱移行细胞癌的潜在标志物。
Clin Cancer Res. 1998 Mar;4(3):535-8.
2
A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.膀胱癌患者尿人端粒酶逆转录酶mRNA诊断及潜在预后效用的前瞻性评估
Can J Urol. 2004 Dec;11(6):2438-44.
3
Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer.评估端粒重复序列扩增法(TRAP)检测端粒酶作为复发性膀胱癌诊断方法的效果。
Clin Cancer Res. 1997 Sep;3(9):1593-8.
4
Telomerase activity: a potential marker of bladder transitional cell carcinoma in bladder washes.端粒酶活性:膀胱冲洗液中膀胱移行细胞癌的潜在标志物。
Yonsei Med J. 1997 Jun;38(3):155-9. doi: 10.3349/ymj.1997.38.3.155.
5
Telomerase activity in patients with transitional cell carcinoma: a preliminary study.移行细胞癌患者的端粒酶活性:一项初步研究。
Cancer. 1999 Feb 15;85(4):919-24.
6
Expression of the human mismatch repair gene hMSH2: a potential marker for urothelial malignancy.人类错配修复基因hMSH2的表达:一种尿路上皮恶性肿瘤的潜在标志物。
Cancer. 2000 May 15;88(10):2333-41.
7
Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma.细胞角蛋白19片段21-1、端粒酶及血管内皮生长因子联合检测在膀胱移行细胞癌诊断中的应用
Int J Urol. 2007 Feb;14(2):108-11. doi: 10.1111/j.1442-2042.2007.01670.x.
8
Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine.人膀胱癌、膀胱冲洗液及尿液中端粒酶活性的非放射性检测
J Pathol. 1998 Jan;184(1):71-6. doi: 10.1002/(SICI)1096-9896(199801)184:1<71::AID-PATH988>3.0.CO;2-#.
9
Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.尿细胞学、UBC-ELISA和荧光原位杂交技术在常规临床实践中对膀胱移行细胞癌检测的比较诊断价值
Urology. 2007 Sep;70(3):449-53. doi: 10.1016/j.urology.2007.04.023. Epub 2007 Aug 3.
10
Telomerase activity and cytokeratin 20 as markers for the detection and followup of transitional cell carcinoma: an unfulfilled promise.
J Urol. 2001 Sep;166(3):841-4.

引用本文的文献

1
Diagnostic Value of Telomerase Activity in Patients With Bladder Cancer: A Meta-Analysis of Diagnostic Test.端粒酶活性在膀胱癌患者中的诊断价值:一项诊断试验的Meta分析
Front Oncol. 2020 Dec 3;10:570127. doi: 10.3389/fonc.2020.570127. eCollection 2020.
2
Jun dimerization protein 2 controls hypoxia-induced replicative senescence via both the p16-pRb and Arf-p53 pathways.Jun二聚化蛋白2通过p16-pRb和Arf-p53途径控制缺氧诱导的复制性衰老。
FEBS Open Bio. 2017 Oct 16;7(11):1793-1804. doi: 10.1002/2211-5463.12325. eCollection 2017 Nov.
3
Telomerase activity in bladder cancer tissue.
膀胱癌组织中的端粒酶活性。
Exp Ther Med. 2010 Jan;1(1):85-88. doi: 10.3892/etm_00000015. Epub 2010 Jan 1.
4
Expression and biological-clinical significance of hTR, hTERT and CKS2 in washing fluids of patients with bladder cancer.膀胱癌患者冲洗液中 hTR、hTERT 和 CKS2 的表达及生物学临床意义。
BMC Urol. 2010 Oct 4;10:17. doi: 10.1186/1471-2490-10-17.
5
Telomerase detection in the diagnosis and prognosis of cancer.端粒酶检测在癌症的诊断和预后中的应用。
Cytotechnology. 2004 Jun;45(1-2):61-74. doi: 10.1007/s10616-004-5126-0.
6
Critical evaluation of urinary markers for bladder cancer detection and monitoring.用于膀胱癌检测和监测的尿液标志物的批判性评估。
Rev Urol. 2008 Spring;10(2):120-35.
7
Urine telomerase: an important marker in the diagnosis of bladder cancer.尿端粒酶:膀胱癌诊断中的一项重要标志物。
Neoplasia. 2004 May-Jun;6(3):234-9. doi: 10.1593/neo.03433.
8
Telomerase activity detected by quantitative assay in bladder carcinoma and exfoliated cells in urine.通过定量检测法在膀胱癌及尿脱落细胞中检测到端粒酶活性。
Neoplasia. 2001 Sep-Oct;3(5):446-50. doi: 10.1038/sj.neo.7900191.